Provided by Tiger Trade Technology Pte. Ltd.

INVESCO PHARMACEUTICALS ETF

128.02
+0.53000.42%
Post-market: 128.020.00000.00%19:30 EDT
Volume:79.01K
Turnover:10.14M
Market Cap:532.56M
PE:6.64
High:129.29
Open:128.37
Low:127.73
Close:127.49
52wk High:131.68
52wk Low:90.01
Shares:4.16M
Float Shares:4.16M
Volume Ratio:4.20
T/O Rate:1.90%
Dividend:1.06
Dividend Rate:0.83%
EPS(TTM):19.29
EPS(LYR):21.73
ROE:23.89%
ROA:0.60%
PB:1.60
PE(LYR):5.89

Loading ...

Amgen, AstraZeneca announce Crossing trial showed ‘meaningful’ improvements

TIPRANKS
·
Aug 27

China's JW Therapeutics Interim Revenue Rises 4.7% on Carteyva Sales

Reuters
·
Aug 27

Amgen, AstraZeneca report CROSSING trial met co-primary and secondary endpoints

TIPRANKS
·
Aug 27

China Approves J&J's Oral Psoriasis Pill, Says Drugmaker

Reuters
·
Aug 27

Johnson & Johnson Says Oral Icotrokinra Approved in China for Moderate-to-Severe Plaque Psoriasis - Statement

THOMSON REUTERS
·
Aug 27

AstraZeneca, Amgen Phase 3 Trial Shows Tezspire Eases Swallowing Difficulties for EoE Patients

MT Newswires Live
·
Aug 27

AstraZeneca-Amgen Asthma Drug Succeeds in Late-Stage Oesophagus Disease Trial

Reuters
·
Aug 27

AbbVie Seeks EMA Approval for Skyrizi Subcutaneous Induction in Crohn’s Disease

Reuters
·
Aug 27

Amgen - Tezspire Safety Profile Consistent with Approved Indications

THOMSON REUTERS
·
Aug 27

Tezspire® Demonstrates Positive Phase 3 Results in Eosinophilic Esophagitis Across Both Co-Primary and All Key Secondary Endpoints

THOMSON REUTERS
·
Aug 27

Abbvie Submits Regulatory Application to Ema for Skyrizi® (Risankizumab) Subcutaneous Induction for Adults with Moderately to Severely Active Crohn's Disease

THOMSON REUTERS
·
Aug 27

Abbott Laboratories Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Aug 27

Eli Lilly & Co. Stock Slips 3.6%, Underperforms Peers

Dow Jones
·
Aug 27

AbbVie Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Aug 27

Sector Update: Healthcare

MT Newswires Live
·
Aug 27

US FDA - Issues Early Alert on Abiomed Heart Pump Controller Purge Cassette Issue

THOMSON REUTERS
·
Aug 27

Eli Lilly Expands Alzheimer’s Pipeline With New Amyloid Phase 1 Trial

TIPRANKS
·
Aug 27

Eli Lilly Stock (LLY) in Focus as Alzheimer’s Blood Test Gets FDA Approval

TIPRANKS
·
Aug 26

Eli Lilly and Co Stock (LLY) Opened Down by 3.57% on Aug 26: Facts Behind the Movement

TradingKey
·
Aug 26

US Companies Face Rise in Cyber Attacks

Reuters
·
Aug 26